|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landi L and Cappuzzo F: Pharmacotherapy
targeting the EGFR oncogene in NSCLC. Expert Opin Pharmacother.
15:2293–2305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Markou A, Sourvinou I, Vorkas PA, Yousef
GM and Lianidou E: Clinical evaluation of microRNA expression
profiling in non small cell lung cancer. Lung Cancer. 81:388–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng H, Talebzadeh-Farrooji M, Osborne MJ,
Prokop JW, McDonald PC, Karar J, Hou Z, He M, Kebebew E, Orntoft T,
et al: LIMD2 is a small LIM-only protein overexpressed in
metastatic lesions that regulates cell motility and tumor
progression by directly binding to and activating the
integrin-linked kinase. Cancer Res. 74:1390–1403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cerutti JM, Oler G, Michaluart P Jr,
Delcelo R, Beaty RM, Shoemaker J and Riggins GJ: Molecular
profiling of matched samples identifies biomarkers of papillary
thyroid carcinoma lymph node metastasis. Cancer Res. 67:7885–7892.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
John B, Enright AJ, Aravin A, Tuschl T,
Sande C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang T, Wang G, Yang L, Peng B, Wen Y,
Ding G and Wang Z: MiR-186 inhibits proliferation, migration, and
invasion of non-small cell lung cancer cells by downregulating Yin
Yang 1. Cancer Biomark. 21:221–228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He M and Xue Y: MicroRNA-148a suppresses
proliferation and invasion potential of non-small cell lung
carcinomas via regulation of STAT3. Onco Targets Ther.
10:1353–1361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren P, Gong F, Zhang Y, Jiang J and Zhang
H: MicroRNA-92a promotes growth, metastasis, and chemoresistance in
non-small cell lung cancer cells by targeting PTEN. Tumour Biol.
37:3215–3225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian W, Wang G, Liu Y, Huang Z, Zhang C,
Ning K, Yu C, Shen Y, Wang M, Li Y, et al: The miR-599 promotes
non-small cell lung cancer cell invasion via SATB2. Biochem Biophys
Res Commun. 485:35–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu FY, Cao XN, Xu QZ, Huang Z, Zhang C,
Ning K, Yu C, Shen Y, Wang M, Li Y, et al: iR-124 modulates
gefitinib resistance through SNAI2 and STAT3 in non-small cell lung
cancer. J Huazhong Univ Sci Technolog Med Sci. 36:839–845. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matthews JM, Lester K, Joseph S and Curtis
DJ: LIM-domain-only proteins in cancer. Nat Rev Cancer. 13:111–122.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo W, Zhang Y, Shi Y, Xi J, Fan H and Xu
S: Decreased expression of miR-204 in plasma is associated with a
poor prognosis in patients with non-small cell lung cancer. Int J
Mol Med. 36:1720–1726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Yu Z, Li Y, Liu S, Gao C, Hou X, Yao
R and Cui L: The tumor suppressor miR-124 inhibits cell
proliferation by targeting STAT3 and functions as a prognostic
marker for postoperative NSCLC patients. Int J Oncol. 46:798–808.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin J, Xu K, Wei J, Heimberger AB, Roth JA
and Ji L: MicroRNA-124 suppresses tumor cell proliferation and
invasion by targeting CD164 signaling pathway in non-small cell
lung cancer. J Gene Ther. 2:62016.PubMed/NCBI
|
|
22
|
Yang Q, Wan L, Xiao C, Hu H, Wang L, Zhao
J, Lei Z and Zhang HT: Inhibition of LHX2 by miR-124 suppresses
cellular migration and invasion in non-small cell lung cancer.
Oncol Lett. 14:3429–3436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang M, Meng B and Liu Y, Yu J, Chen Q and
Liu Y: MiR-124 inhibits growth and enhances radiation-induced
apoptosis in non-small cell lung cancer by inhibiting STAT3. Cell
Physiol Biochem. 44:2017–2028. 2017. View Article : Google Scholar : PubMed/NCBI
|
